Atlas Trials

Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDL

Clinical trial NCT00982774 · COMPLETED

Trial details

NCT number
NCT00982774
Sponsor
Access to Advanced Health Institute (AAHI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Post Kala Azar Dermal Leishmaniasis
Start date
2009-04-01
Primary completion
2011-04-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.